好评率
100%
  • Li X; Liu C; Zhang X, et al., Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer. Biomed Pharmacother 2023, 168, 115784.
    IF: 7.5
    Year: 2023 Journal: Biomed Pharmacother
    PubMed: 37879215
  • Cheng C; Tang S; Cui S, et al., Nerve growth factor promote osteogenic differentiation of dental pulp stem cells through MEK/ERK signalling pathways. J Cell Mol Med 2024, 28 (4), e18143.
    IF: 5.3
    Year: 2024 Journal: J Cell Mol Med
    PubMed: 38333908
  • Duan J; Chen H; Li Y, et al., 17beta-Estradiol Enhances Porcine Meiosis Resumption from Autophagy-Induced Gap Junction Intercellular Communications and Connexin 43 Phosphorylation via the MEK/ERK Signaling Pathway. J Agric Food Chem 2021, 69 (40), 11847-11855.
    IF: 5.279
    Year: 2021 Journal: J Agric Food Chem
    PubMed: 34609142
  • Liu M; Hu Q; Tu M, et al., MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. J Exp Clin Cancer Res 2018, 37 (1), 10.
    IF: 5.189
    Year: 2018 Journal: J Exp Clin Cancer Res
    PubMed: 29357919
  • Jian Q; Yang Z; Shu J, et al., Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3beta/beta-catenin pathway in hepatocellular carcinoma. J Cell Mol Med 2018, 22 (1), 315-329.
    IF: 4.499
    Year: 2017 Journal: J Cell Mol Med
    PubMed: 28922551
  • Li R; Qi Y; Yuan Q, et al., Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCepsilon/ERK-mediated oxidative stress. Eur J Pharmacol 2021, 907, 174277.
    IF: 3.263
    Year: 2021 Journal: Eur J Pharmacol
    PubMed: 34171391
  • Pan Z; Wang K; Chen Q, et al., SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells. J Cancer 2020, 11 (2), 334-344.
    IF: 3.182
    Year: 2020 Journal: J Cancer
    PubMed: 31897229
  • Wang P F; Wang Z F; Qiu H Y, et al., Identification and Biological Evaluation of Novel Type II B-Raf(V600E) Inhibitors. ChemMedChem 2018, 13 (23), 2558-2566.
    IF: 3.009
    Year: 2018 Journal: ChemMedChem
    PubMed: 30353975
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序